Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution ’s experience in Korea

ConclusionPatients with ER-low/HER2 − breast cancer had similar clinicopathological characteristics, treatments, and outcomes as patients with TNBC irrespective of disease setting. Further research is needed to understand predictive and prognostic factors associated with ER-low/HER2− disease.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research